Developing Targeted Therapies to Address Resistance in Cancer
Vishal Doshi, chairman and CEO of AUM Biosicences, discusses the development of resistance in cancers, the case of combining precision therapies with immunotherapies, and why he believes we can transform cancer from a deadly condition to a chronic disease.